Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results

BACKGROUND: There is growing evidence that prostate cancer (PC) cells are more sensitive to high fraction dose in hypofractionation schemes. High-dose-rate (HDR) brachytherapy as monotherapy is established to be a good treatment option for PC using extremely hypofractionated schemes. This hypofracti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Aluwini, Shafak, van Rooij, Peter, Hoogeman, Mischa, Kirkels, Wim, Kolkman-Deurloo, Inger-Karine, Bangma, Chris
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641975/
https://ncbi.nlm.nih.gov/pubmed/23570391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-84
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki